ObjectivesOrganized, population-based cancer screening is recommended by European Union guidelines. Employer-provided screening within Workplace Health Promotion (WHP) programs may differ from evidence-based guidelines. This study aimed to evaluate the alignment between international cancer screening recommendations and screening services offered by companies participating in the Lombardy WHP Program.MethodsA cross-sectional survey was conducted between April and September 2024 among companies participating in the Lombardy WHP Program. Screening practices for breast, cervical, colorectal, prostate, and lung cancer were compared with the most recent international guidelines. Company characteristics were analyzed using descriptive statistics and univariate logistic regression models.ResultsOf the 308 companies participating in the survey, 95 reported the inclusion of preventive medicine services in their corporate welfare offer. Among these, breast cancer screening was the most frequently offered service (67.4%), followed by cervical cancer screening (57.9%). Both the majority of mammography offers (51%) and Pap test offers (92.6%) were not guideline-adherent, thus resulting in overscreening. Colorectal cancer (41.1%) and lung cancer (33.7%) screening were even less commonly provided by the participating companies. Prostate cancer screening with PSA testing was available in 63.2% of participating companies. Large companies had significantly lower odds of inappropriate mammography intervals (OR 0.11; 95% CI 0.02-0.58).ConclusionCancer screening services offered by companies, compliant with the Lombardy WHP Program, are frequently not aligned with current evidence-based recommendations, with overscreening emerging as a predominant issue. Strengthening coordination between occupational health services and public health authorities is essential to ensure appropriate, equitable, and sustainable integration of workplace-based screening initiatives into organized regional cancer prevention strategies.
Adherence to Cancer Screening Guidelines in Employer-Provided Healthcare Programs: A Survey of Companies in Lombardy (Northern Italy) / F. Scovenna, P.B.. - In: CANCER CONTROL. - ISSN 1526-2359. - 33:(2026 Dec), pp. 1-12. [10.1177/10732748261491831]
Adherence to Cancer Screening Guidelines in Employer-Provided Healthcare Programs: A Survey of Companies in Lombardy (Northern Italy)
F. ScovennaPrimo
;S. Piccinelli;A. Pedot;F. Ferrè;V. Barbera;F.E. Pregliasco
;D. CeredaPenultimo
;S. DeandreaUltimo
2026
Abstract
ObjectivesOrganized, population-based cancer screening is recommended by European Union guidelines. Employer-provided screening within Workplace Health Promotion (WHP) programs may differ from evidence-based guidelines. This study aimed to evaluate the alignment between international cancer screening recommendations and screening services offered by companies participating in the Lombardy WHP Program.MethodsA cross-sectional survey was conducted between April and September 2024 among companies participating in the Lombardy WHP Program. Screening practices for breast, cervical, colorectal, prostate, and lung cancer were compared with the most recent international guidelines. Company characteristics were analyzed using descriptive statistics and univariate logistic regression models.ResultsOf the 308 companies participating in the survey, 95 reported the inclusion of preventive medicine services in their corporate welfare offer. Among these, breast cancer screening was the most frequently offered service (67.4%), followed by cervical cancer screening (57.9%). Both the majority of mammography offers (51%) and Pap test offers (92.6%) were not guideline-adherent, thus resulting in overscreening. Colorectal cancer (41.1%) and lung cancer (33.7%) screening were even less commonly provided by the participating companies. Prostate cancer screening with PSA testing was available in 63.2% of participating companies. Large companies had significantly lower odds of inappropriate mammography intervals (OR 0.11; 95% CI 0.02-0.58).ConclusionCancer screening services offered by companies, compliant with the Lombardy WHP Program, are frequently not aligned with current evidence-based recommendations, with overscreening emerging as a predominant issue. Strengthening coordination between occupational health services and public health authorities is essential to ensure appropriate, equitable, and sustainable integration of workplace-based screening initiatives into organized regional cancer prevention strategies.| File | Dimensione | Formato | |
|---|---|---|---|
|
scovenna-et-al-2026-adherence-to-cancer-screening-guidelines-in-employer-provided-healthcare-programs-a-survey-of.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
408.66 kB
Formato
Adobe PDF
|
408.66 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in AIR sono rilasciati con licenza CCO mentre i file delle pubblicazioni sono rilasciati con licenza CC BY-SA, salvo diversa indicazione. In caso di violazione di copyright, contattare l'assistenza di AIR




